Signaling via tumor necrosis factor receptor 1 but not toll-like receptor 2 contributes significantly to hydrosalpinx development following Chlamydia muridarum infection

Infection and Immunity

Volumn 82, Issue 5, 2014, Pages 1833-1839

  Dong, Xiaohua ^a,b   Liu, Yuanjun ^a   Chang, Xiaotong ^a,b   Lei, Lei ^a   Zhong, Guangming ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b HEBEI NORTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HYDROSALPINX; IMMUNOPATHOGENESIS; IN VITRO STUDY; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; WILD TYPE;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; FALLOPIAN TUBE DISEASES; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; VAGINITIS;

EID: 84898895139     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01668-13     Document Type: Article

References (46)

1. Sherman KJ, Daling JR, Stergachis A, Weiss NS, Foy HM, Wang SP, Grayston JT. 1990. Sexually transmitted diseases and tubal pregnancy. Sex Transm. Dis. 17:115-121. http://dx.doi.org/10.1097/00007435-199007000-00001.
2. Cotter TW, Meng Q, Shen ZL, Zhang YX, Su H, Caldwell HD. 1995. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect. Immun. 63:4704-4714.
3. Pal S, Peterson EM, de la Maza LM. 2005. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect. Immun. 73:8153-8160. http://dx.doi.org/10.1128/IAI.73.12.8153 -8160.2005.
4. Lu H, Zhong G. 1999. Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection. Infect. Immun. 67:1763-1769.
5. Murthy AK, Sharma J, Coalson JJ, Zhong G, Arulanandam BP. 2004. Chlamydia trachomatis pulmonary infection induces greater inflammatory pathology in immunoglobulin A deficient mice. Cell Immunol. 230: 56-64. http://dx.doi.org/10.1016/j.cellimm.2004.09.002.
6. Morrison SG, Morrison RP. 2005. A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J. Immunol. 175:7536-7542.
7. Morrison RP, Caldwell HD. 2002. Immunity to murine chlamydial genital infection. Infect. Immun. 70:2741-2751. http://dx.doi.org/10.1128 /IAI.70.6.2741-2751.2002.
8. Perfettini JL, Darville T, Gachelin G, Souque P, Huerre M, Dautry-Varsat A, Ojcius DM. 2000. Effect of Chlamydia trachomatis infection and subsequent tumor necrosis factor alpha secretion on apoptosis in the murine genital tract. Infect. Immun. 68:2237-2244. http://dx.doi.org/10.1128/IAI.68.4.2237-2244.2000.
9. Darville T, O'Neill JM, Andrews CW, Jr, Nagarajan UM, Stahl L, Ojcius DM. 2003. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J. Immunol. 171:6187-6197.
10. Yang X, Gartner J, Zhu L, Wang S, Brunham RC. 1999. IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J. Immunol. 162:1010-1017.
11. Reddy BS, Rastogi S, Das B, Salhan S, Verma S, Mittal A. 2004. Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women-implication for T-cell responses. Clin. Exp. Immunol. 137:552-558. http://dx.doi.org/10.1111/j.1365-2249.2004.02564.x.
12. Darville T, Andrews CW, Jr, Sikes JD, Fraley PL, Rank RG. 2001. Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection. Infect. Immun. 69:3556-3561. http: //dx.doi.org/10.1128/IAI.69.6.3556-3561.2001.
13. Bas S, Neff L, Vuillet M, Spenato U, Seya T, Matsumoto M, Gabay C. 2008. The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/ TLR6 and CD14. J. Immunol. 180:1158-1168.
14. Chen L, Lei L, Chang X, Li Z, Lu C, Zhang X, Wu Y, Yeh IT, Zhong G. 2010. Mice deficient in MyD88 develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection. J. Immunol. 184:2602-2610. http://dx.doi.org/10.4049 /jimmunol.0901593.
15. Lu C, Peng B, Li Z, Lei L, Chen L, He Q, Zhong G, Wu Y. 2013. Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator. Microbes Infect. 15:329-338. http://dx.doi.org/10.1016/j.micinf.2013.02.001.
16. Cheng W, Shivshankar P, Li Z, Chen L, Yeh IT, Zhong G. 2008. Caspase-1 contributes toChlamydiatrachomatis-induced upper urogenital tractinflammatory pathologies without affecting the course of infection. Infect.Immun.76:515-522. http://dx.doi.org/10.1128/IAI.01064-07.
17. Cheng W, Shivshankar P, Zhong Y, Chen D, Li Z, Zhong G. 2008. Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor. Infect. Immun. 76:942-951. http://dx.doi.org/10.1128/IAI.01313-07.
18. Su H, McClarty G, Dong F, Hatch GM, Pan ZK, Zhong G. 2004. Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J. Biol. Chem. 279: 9409-9416. http://dx.doi.org/10.1074/jbc.M312008200.
19. Shah AA, Schripsema JH, Imtiaz MT, Sigar IM, Kasimos J, Matos PG, Inouye S, Ramsey KH. 2005. Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex Transm. Dis. 32:49-56. http://dx.doi.org/10.1097/01.olq.0000148299.14513.11.
20. Chen L, Lei L, Zhou Z, He J, Xu S, Lu C, Chen J, Yang Z, Wu G, Yeh IT, Zhong G, Wu Y. 2013. Contribution of interleukin-12 p35 (IL-12p35) and IL-12p40 to protective immunity and pathology in mice infected with Chlamydia muridarum. Infect. Immun. 81:2962-2971. http://dx.doi.org /10.1128/IAI.00161-13.
21. Lu C, Zeng H, Li Z, Lei L, Yeh IT, Wu Y, Zhong G. 2012. Protective immunity against mouse upper genital tract pathology correlates with high IFNgamma but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway. Vaccine 30:475-485. http://dx.doi.org/10.1016/j.vaccine.2011.10.059.
22. Lei L, Chen J, Hou S, Ding Y, Yang Z, Zeng H, Baseman J, Zhong G. 2013. Reduced live organism recovery and lack of hydrosalpinx in mice infected with plasmid-free Chlamydia muridarum. Infect. Immun. 82: 983-992. http://dx.doi.org/10.1128/IAI.01543-13.
23. Tang L, Yang Z, Zhang H, Zhou Z, Arulanandam B, Baseman J, Zhong G. 1 November 2013. Induction of protective immunity against Chlamydia muridarum intracervical infection in DBA/1j mice. Vaccine http: //dx.doi.org/10.1016/j.vaccine.2013.10.018.
24. Tang L, Zhang H, Lei L, Gong S, Zhou Z, Baseman J, Zhong G. 2013. Oviduct infection and hydrosalpinx in DBA1/j mice is induced by intracervical but not intravaginal inoculation with Chlamydia muridarum. PLoS One 8:e71649. http://dx.doi.org/10.1371/journal.pone.0071649.
25. Kumar S, Ingle H, Prasad DV, Kumar H. 2013. Recognition of bacterial infection by innate immune sensors. Crit. Rev. Microbiol. 39:229-246. http://dx.doi.org/10.3109/1040841X.2012.706249.
26. Yamamoto M, Takeda K. 2010. Current views of toll-like receptor signaling pathways. Gastroenterol. Res. Pract. 2010:240365. http://dx.doi.org/10.1155/2010/240365.
27. Waters JP, Pober JS, Bradley JR. 2013. Tumour necrosis factor in infectious disease. J. Pathol. 230:132-147. http://dx.doi.org/10.1002/path.4187.
28. Twu YC, Gold MR, Teh HS. 2011. TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells. Eur. J. Immunol. 41:335-344. http://dx.doi.org/10.1002/eji.201040639.
29. Aggarwal BB. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3:745-756. http://dx.doi.org/10.1038/nri1184.
30. Pal S, de la Maza LM. 2013. Mechanism of T-cell mediated protection in newborn mice against a Chlamydia infection. Microbes Infect. 15:607-614. http://dx.doi.org/10.1016/j.micinf.2013.04.010.
31. Kamalakaran S, Chaganty BK, Gupta R, Guentzel MN, Chambers JP, Murthy AK, Arulanandam BP. 2013. Vaginal chlamydial clearance following primary or secondary infection in mice occurs independently of TNF-alpha. Front. Cell Infect. Microbiol. 3:11. http://dx.doi.org/10.3389 /fcimb.2013.00011.
32. Ohman H, Tiitinen A, Halttunen M, Lehtinen M, Paavonen J, Surcel HM. 2009. Cytokine polymorphisms and severity of tubal damage in women with Chlamydia-associated infertility. J. Infect. Dis. 199:1353-1359. http://dx.doi.org/10.1086/597620.
33. Murthy AK, Li W, Chaganty BK, Kamalakaran S, Guentzel MN, Seshu J, Forsthuber TG, Zhong G, Arulanandam BP. 2011. Tumor necrosis factor alpha production from CD8+T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect. Immun. 79:2928-2935. http://dx.doi.org/10.1128/IAI.05022-11.
34. Chen C, Chen D, Sharma J, Cheng W, Zhong Y, Liu K, Jensen J, Shain R, Arulanandam B, Zhong G. 2006. The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis. Infect. Immun. 74:4826-4840. http://dx.doi.org/10.1128/IAI.00081-06.
35. Murthy AK, Chambers JP, Meier PA, Zhong G, Arulanandam BP. 2007. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect. Immun. 75:666-676. http://dx.doi.org/10.1128 /IAI.01280-06.
36. Li Z, Lu C, Peng B, Zeng H, Zhou Z, Wu Y, Zhong G. 2012. Induction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylase. PLoS One 7:e32997. http: //dx.doi.org/10.1371/journal.pone.0032997.
37. Zhong G, Fan P, Ji H, Dong F, Huang Y. 2001. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193:935-942. http://dx.doi.org/10.1084/jem.193.8.935.
38. Zhong G, Reis e Sousa C, Germain RN. 1997. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc. Natl. Acad. Sci. U. S. A. 94:13856-13861. http://dx.doi.org/10.1073/pnas.94.25.13856.
39. Zhong G, Toth I, Reid R, Brunham RC. 1993. Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis. J. Immunol. 151:3728-3736.
40. Zhong GM, Brunham RC. 1990. Immunoaccessible peptide sequences of the major outer membrane protein from Chlamydia trachomatis serovar C. Infect. Immun. 58:3438-3441.
41. Sharma J, Bosnic AM, Piper JM, Zhong G. 2004. Human antibody responses to a Chlamydia-secreted protease factor. Infect. Immun. 72: 7164-7171. http://dx.doi.org/10.1128/IAI.72.12.7164-7171.2004.
42. Budrys NM, Gong S, Rodgers AK, Wang J, Louden C, Shain R, Schenken RS, Zhong G. 2012.Chlamydiatrachomatis antigens recognized in women with tubal factor infertility, normal fertility, and acute infection. Obstet. Gynecol. 119:1009-1016. http://dx.doi.org/10.1097/AOG.0b013e3182519326.
43. Rodgers AK, Budrys NM, Gong S, Wang J, Holden A, Schenken RS, Zhong G. 2011. Genome-wide identification of Chlamydia trachomatis antigens associated with tubal factor infertility. Fertil. Steril. 96:715-721. http://dx.doi.org/10.1016/j.fertnstert.2011.06.021.
44. Laisk T, Peters M, Saare M, Haller-Kikkatalo K, Karro H, Salumets A. 2010. Association of CCR5, TLR2, TLR4 and MBL genetic variations with genital tract infections and tubal factor infertility. J. Reprod. Immunol. 87:74-81. http://dx.doi.org/10.1016/j.jri.2010.06.001.
45. Andrew DW, Cochrane M, Schripsema JH, Ramsey KH, Dando SJ, O'Meara CP, Timms P, Beagley KW. 2013. The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization. PLoS One 8:e76664. http://dx.doi.org /10.1371/journal.pone.0076664.
46. Fei M, Bhatia S, Oriss TB, Yarlagadda M, Khare A, Akira S, Saijo S, Iwakura Y, Fallert Junecko BA, Reinhart TA, Foreman O, Ray P, Kolls J, Ray A. 2011. TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection. Proc. Natl. Acad. Sci. U. S. A. 108:5360-5365. http://dx.doi.org/10.1073/pnas.1015476108.